(Q46780453)

English

Potential relationships between transaminase abnormality and valproic acid clearance or serum carnitine concentrations in Japanese epileptic patients

scientific article published in February 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18237476

Potential relationships between transaminase abnormality and valproic acid clearance or serum carnitine concentrations in Japanese epileptic patients (English)

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18237476

author name string

Shuji Goto

1

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18237476

Takayuki Seo

2

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18237476

Takashi Hagiwara

3

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18237476

Kentaro Ueda

4

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18237476

Tsuyuko Yamauchi

5

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18237476

Shiro Nagata

6

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18237476

Yukio Ando

7

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18237476

Takateru Ishitsu

8

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18237476

Kazuko Nakagawa

9

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18237476

publication date

1 February 2008

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18237476

Journal of Pharmacy and Pharmacology

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18237476

60

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18237476

2

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18237476

267-272

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18237476

Serum transaminase elevations as indicators of hepatic injury following the administration of drugs

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0017

21 January 2018

Valproic acid (VPA) in patients with refractory advanced cancer: a dose escalating phase I clinical trial

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0017

21 January 2018

Oxidative stress as a mechanism of valproic acid-associated hepatotoxicity

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0017

21 January 2018

Plasma free carnitine in epilepsy children, adolescents and young adults treated with old and new antiepileptic drugs with or without ketogenic diet.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0017

21 January 2018

l-Carnitine Supplementation in Childhood Epilepsy: Current Perspectives

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0017

21 January 2018

Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0017

21 January 2018

Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0017

21 January 2018

The role of the carnitine system in human metabolism

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0017

21 January 2018

Capillary microscopy and hemorheology in children during antiepileptic monotherapy with carbamazepine and valproate.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0017

21 January 2018

Idiosyncratic drug hepatotoxicity

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0017

21 January 2018

Valproic acid-induced hepatopathy: nine new fatalities in Germany from 1994 to 2003.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0017

21 January 2018

Abnormal alterations in the metabolic patterns of patients on valproate therapy

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0017

21 January 2018

Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28,838 middle-aged men and women

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0017

21 January 2018

Effects of polytherapy with phenytoin, carbamazepine, and stiripentol on formation of 4-ene-valproate, a hepatotoxic metabolite of valproic acid

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0017

21 January 2018

Science review: carnitine in the treatment of valproic acid-induced toxicity - what is the evidence?

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0017

21 January 2018

L-carnitine was safely administered in the setting of valproate toxicity

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0017

21 January 2018

Valproate therapy and nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0017

21 January 2018

Valproate: a simple chemical with so much to offer.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0017

21 January 2018

Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0017

21 January 2018

Characterization of insulin secretion in Valproate-treated patients with epilepsy.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0017

21 January 2018

The role of carnitine supplementation during valproic acid therapy

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0017

21 January 2018

Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0017

21 January 2018

Drug-induced liver injury: summary of a single topic clinical research conference

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0017

21 January 2018

Pharmacoepidemiologic investigation of a clonazepam-valproic acid interaction by mixed effect modeling using routine clinical pharmacokinetic data in Japanese patients

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0017

21 January 2018

Identifiers

10.1211/JPP.60.2.0017

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18237476

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18237476

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46780453&oldid=2131131799"